チームみらい安野貴博が「成果連動型診療報酬制度」を解説：膨らむ医療費問題への新提案
By
TOKYO MX
Summary
この記事は、TOKYO MXの番組「堀潤激論サミット」で取り上げられた、増加し続ける日本の医療費問題と、政治団体「チームみらい」が提案する「成果連動型診療報酬制度」について報じている。2023年度の医療費総額が48兆円と過去最高を更新する中、2026年6月からの診療報酬改定で初診料や再診料が引き上げられる一方、高齢者の窓口負担引き上げ案も議論されている。チームみらいの党首・安野貴博氏は、従来の診療回数ベースではなく治療成果に連動した新たな診療報酬制度を提案し、医療費削減の3つのポイントを挙げている。
Source
bskyチームみらい安野貴博が「成果連動型診療報酬制度」を解説：膨らむ医療費問題への新提案news.yahoo.co.jpKey quotes
· 3 pulled年々膨らみ続ける医療費問題にチームみらいからの提案「成果連動型診療報酬制度」を安野貴博が解説
2023年度の医療費の総額は48兆円と過去最高を更新
チームみらいが掲げる新たな診療報酬制度「成果連動型診療報酬」が注目を集めています
You might also wanna read
The Human Toll of USAID's Dismantling: 800,000 Estimated Deaths
This article examines the devastating human consequences of the Trump administration's decision to dismantle the US Agency for International
timhirschelburns.substack.com·7h ago
Amnesty International UK demands government cancel Palantir's NHS patient data contract over Israel military ties
Amnesty International UK is demanding the UK government cancel its contract with Palantir Technologies, arguing the US software company shou
amnesty.org.uk·15h ago
SignHealth backs petition for BSL interpretation at emergency scenes after dispatch
SignHealth, a deaf health charity, has endorsed a petition by Elizabeth Corbett demanding that British Sign Language (BSL) interpretation be
zurl.co·16h ago
Letters to the editor criticize Canadian Dental Care Plan for accessibility gaps and lack of accountability
This article compiles multiple letters to the editor criticizing the Canadian Dental Care Plan (CDCP) for its lack of transparency, eligibil
en.killbait.com·17h ago
BMA Launches Legal Challenge Against Government Over GMC Appeal Powers
The British Medical Association (BMA) has launched legal action against the UK government over plans to retain and expand the General Medica
mdsc.pe·20h ago
Analysis: US-UK trade deal could force NHS to divert billions to medicines, critics warn
Analysis claims the US-UK trade deal agreed in December will force the NHS to divert billions from essential services to pay for new medicin
theguardian.com·1d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.